Support NHLBI Intramural researchers transitioning to independent investigators at external institutions via K22 grant funding.
Funder: National Institutes of Health
Due Dates: November 12, 2026 (Resubmission) | February 12, 2027 (New) | March 12, 2027 (Resubmission) | June 12, 2027 (New) | July 12, 2027 (Resubmission)
Funding Amounts: Up to $249,000 annually ($747,000 total) for three extramural years, following up to two intramural years
Summary: Supports NHLBI intramural trainees transitioning to independent research careers at extramural institutions.
Key Information: Only the NHLBI intramural program may submit initial applications on behalf of its trainees.
The National Heart, Lung, and Blood Institute (NHLBI) administers this K22 Career Transition Award for highly qualified postdoctoral fellows and other doctoral-level researchers training in its Division of Intramural Research. It supports mentored intramural research followed by an independent extramural research project, helping newly trained basic and clinical investigators establish independent research careers and subsequently compete for funding such as an R01.
Research must be relevant to NHLBI’s mission. Candidates may not lead an independent clinical trial, clinical trial feasibility study, or ancillary clinical trial under this opportunity. Research experience in a clinical trial led by a mentor or co-mentor is permitted. Candidates proposing to lead clinical trials should use the companion opportunity, PAR-24-211.